Skip to main content
Premium Trial:

Request an Annual Quote

DNA2.0 to Open UK Office for European Synthetic Gene Market

NEW YORK (GenomeWeb News) – California-based gene synthesis firm DNA2.0 is expanding by opening an arm in the UK called DNA2.0 Ltd., the company said today.
The company, which supplies synthetic genes to academic and government customers, as well as companies in the pharmaceutical, biotechnology, chemical, agricultural fields, already has a European office in Basel, Switzerland.
"Even in a time of economic uncertainty, the market for gene synthesis and its many applications continues to grow rapidly in Europe,” DNA2.0 President Jeremy Minshull said in a statement.
The UK headquarters will be run by Michael Dyson, who has been appointed managing director of European operations and who runs the company’s Switzerland office.

The Scan

Missed Early Cases

A retrospective analysis of blood samples suggests early SARS-CoV-2 infections may have been missed in the US, the New York Times reports.

Limited Journal Editor Diversity

A survey finds low diversity among scientific and medical journal editors, according to The Scientist.

How Much of a Threat?

Science writes that need for a provision aimed at shoring up genomic data security within a new US bill is being questioned.

PNAS Papers on Historic Helicobacter Spread, Brain Development, C. difficile RNAs

In PNAS this week: Helicobacter genetic diversity gives insight into human migrations, gene expression patterns of brain development, and more.